Jasper Therapeutics Inc (JSPR) is up 2.66% in a Week, Should You Sell?

Jasper Therapeutics Inc (JSPR) is around the top of the Biotechnology industry according to InvestorsObserver. JSPR received an overall rating of 79, which means that it scores higher than 79 percent of all stocks. Jasper Therapeutics Inc also achieved a score of 94 in the Biotechnology industry, putting it above 94 percent of Biotechnology stocks. Biotechnology is ranked 19 out of the 148 industries.

JSPR has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on JSPR!

See Full JSPR Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 79 would rank higher than 79 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Jasper Therapeutics Inc Stock Today?

Jasper Therapeutics Inc (JSPR) stock is trading at $30.46 as of 10:33 AM on Thursday, Mar 28, a rise of $1.64, or 5.69% from the previous closing price of $28.82. The stock has traded between $29.88 and $31.00 so far today. Volume today is low. So far 19,452 shares have traded compared to average volume of 131,620 shares. Click Here to get the full Stock Report for Jasper Therapeutics Inc stock.